Recent Finacing
Recent Raise
Syros Pharmaceuticals develops gene-control therapies using a proprietary platform that maps gene-regulatory switches (e.g., super-enhancers) in human disease tissue to discover therapeutics and biomarkers for cancer and other indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors